Study on the effects of the TT1 prescription in treating light and medium hypertension without blood lipid metabolic disorder

ABSTRACT

A controlled prospective study included 50 normal Swiss white mice and 62 patients with mild and moderate hypertension without blood lipid metabolic disorder were divided into two groups randomly. The control group 31 patients treated by Caporil 25mg, two tablets twice daily, (at 12 hours intervals). The study group 31 take a TT1 prescription daily within 28 days continuously. The result showed that No acute toxicity from TT1 prescription on trial dose of white mice 50g/kg. No side effects occur when the patient uses a TT1 prescription daily. No blood lipid metabolic disorder on mild and moderate hypertension patients. TT1 had clearly good efficacy on hypotension. This efficacy after two weeks treatment is less effective than Caporil 25mg, twice daily but equivalent with Caporil 25mg, twice daily after 4 weeks. Some symptoms such as dazzle, dizziness, headache, red face, red eyes, tightness on chest had improved by TT1 and it was much better than Caporil.